Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels

Urology

Volumn 47, Issue 5, 1996, Pages 699-703

  Schmid, H P ^a,b   Ravery, V ^a   Billebaud, T ^a   Toublanc, M ^a   Boccon Gibod, L A ^a   Hermieu, J F ^a   Delmas, V ^a   Boccon Gibod, L ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL FEATURE; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROSTATISM; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0029956021     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00018-0     Document Type: Article

References (22)

1. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
2. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
3. Benson MC, Whang IS, Olsson CA, McMahon DJ, and Cooner WH: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147: 817-821, 1992.
4. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, and Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215-2220, 1992.
5. Schmid H-P, McNeal JE, and Stamey TA: Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031-2040, 1993.
6. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, and Lovgrent T: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
7. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, and Alfthan O: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
8. Hodge KK, McNeal JE, Terris MK, and Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-75, 1989.
9. Ramon J, Boccon-Gibod L, Billebaud T, Astier L, Kobelinsky M, Meulemans A, Dauge MC, Boccon-Gibod L, and Villers A: Prostate-specific antigen density: a means to enhance detection of prostate cancer. Eur Urol 25: 288-294, 1994.
10. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147: 841-845, 1992.
11. Vallancien G, Prapotnich D, Veillon B, Brisset JM, and Andre-Bougaran J: Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146: 1308-1312, 1991.
12. Lepor H, Owens RS, Rogenes V, and Kuhn E: Detection of prostate cancer in males with prostatism. Prostate 25: 132-140, 1994.
13. Kirby RS, Kirby MG, Feneley MR, McNicholas T, McLean A, and Webb JA: Screening for carcinoma of the prostate: a GP based study. Br J Urol 74: 64-71, 1994.
14. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Toublanc M, and Boccon-Gibod L: Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistant/recurrent detectable PSA after radical prostatectomy. Urology 44: 371-376, 1994.
15. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 45: 2-12, 1995.
16. Brawer MK, Beatie J, Wener MH, Vessela RL, Preston SD, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 150: 106-109, 1993.
17. Babaian RJ, Miyashita H, Evans RB, and Ramirez EI: The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 147: 837-840, 1992.
18. Semjonow A, Hamm M, Rathert P, and Hertle L: Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer. Br J Urol 73: 538-543, 1994.
19. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, and Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146-1152, 1990.
20. Hammerer P, and Huland H: Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151: 99-102, 1994.
21. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, and Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150: 110-114, 1993.
22. Andriole GL: Screening for prostate cancer based on prostate-specific antigen. Eur Urol 27(2): 6-8, 1995.